Skip to main content
SpringerLink
Log in

Worin besteht die galenische Innovation bei Enantone® Monats-Depot?

  • Conference paper
Endokrine Therapie des fortgeschrittenen Prostatakarzinoms

  • 18 Accesses

Zusammenfassung

Zunächst soll in einem kurzen Abriß die Geschichte dieser Entwicklung geschildert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aird CC, Matory WF (1974) Experimental evaluation of Dexon suture in the dog. H Natl Med Assoc 66: 424–425

    CAS  Google Scholar 

  2. Anik S et al. (1984) Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6] LHRH, in rhesus monkeys. I. J Pharm Sci 73: 684–685

    Article  CAS  Google Scholar 

  3. Arimura A et al. (1979) Reduction of testicular luteinizing hormone/human chlorionic gonadotropin receptors by [D Trp6]-luteinizing hormone releasing hormone in hypophysectomized rats. Biochem Biophys Res Commun 90 (3): 687–693

    Article  PubMed  CAS  Google Scholar 

  4. Conn J jr et al. (1974) Vicryl (Polyglactin 910) synthetic absorbable sutures. Am J Surg 128: 142–152

    Article  Google Scholar 

  5. Cutright DE et al. (1981) Histologic comparison of polylactic and polyglycolic acid sutures. Oral Surg 32: 165–173

    Article  Google Scholar 

  6. Eisenberger MA et al. (1986) Gondotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma. J Clin Oncol 4 (3): 414–424

    PubMed  CAS  Google Scholar 

  7. Harris GW (1948) Neural Control of the Pituitary Gland. Physiol Rev 28 (2): 139–179

    PubMed  CAS  Google Scholar 

  8. Huggins C et al. (1941) Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293–297

    CAS  Google Scholar 

  9. Kulkarni DE et al. (1966) Polylactic acid for surgical implants. Arch Surg 93: 839–843

    PubMed  CAS  Google Scholar 

  10. Matsuo H et al. (1981) Structure of the Porcine LH- and FSHreleasing-hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun 43 (6): 1334–1339

    Article  Google Scholar 

  11. Mazzei Tet al. (1990) Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. J Intern Med Res 18 (Suppl 1): 42–56

    Google Scholar 

  12. OgawaYet al. (1989) Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals. J Pharm Pharmacol 41: 439–444

    Article  PubMed  CAS  Google Scholar 

  13. Pasimeni A (1976) Ricerche sull’attivita’ teratogena e cancerogena di un materiale du sutura sintetica: il „dexon green“.. Studi Urbinati-Serie di Farmacia 49: 173–194

    CAS  Google Scholar 

  14. Pasimeni A (1976) Ricerche tossicologiche su un materiale di satura sintetica: il „dexon green“. Studi Urbinati-Serie di Farmacia 49: 195–221

    CAS  Google Scholar 

  15. Schally AV et al. (1985) New approaches to treatment of hormone dependent prostate and mammary tumors with LH-RH analogs. In: Movin RJ, Bing RJ (eds) Frontiers in Medicine. Implications for the Future. Human Sciences Press, New York, pp 165–185

    Google Scholar 

  16. Shimamoto T et al. (1987) Pharmaceutical aspects. Nasal and depot formulation of leuprorelide. J Androl 8 (1): 14–16

    Google Scholar 

  17. Vischer GE et al. (1985) Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. J Biomed Mat Res 19: 349–365

    Article  Google Scholar 

  18. Wise D et al. (1976) Sustained release of an antimaterial drug using a copolymer of glycolic lactic acid. Life Sci 19: 867–874

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Hübner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik, Medizinische Fakultät der RWTH Aachen, Pauwelsstraße 30, W-5100, Aachen, Deutschland

    Gerhard Jakse  & Johannes Wolff  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hübner, R. (1992). Worin besteht die galenische Innovation bei Enantone® Monats-Depot?. In: Jakse, G., Wolff, J. (eds) Endokrine Therapie des fortgeschrittenen Prostatakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76866-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76866-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76867-5

  • Online ISBN: 978-3-642-76866-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation